| The Impact of Surgical Complications on Obstetricians’ and Gynecologists' Wellbeing and Coping Mechanisms as Second Victims R Collings, C Potter, V Gebski, M Janda, A Obermair American Journal of Obstetrics and Gynecology, 2024 | | 2024 |
| Effect of a correlated competing risk on marginal survival estimation in an accelerated failure time model V Gares, M Hudson, M Manuguerra, V Gebski Communications in Statistics-Simulation and Computation, 1-23, 2024 | | 2024 |
| Phase II study of neoadjuvant ipilimumab and nivolumab in combination with paclitaxel following anthracycline-based chemotherapy in patients with treatment resistant stage III … S Loi, PA Francis, N Zdenkowski, V Gebski, SB Fox, M White, BE Kiely, ... Journal of Clinical Oncology 42 (16_suppl), 608-608, 2024 | 2 | 2024 |
| LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer PT Ramirez, KP Robledo, M Frumovitz, R Pareja, R Ribeiro, A Lopez, ... Journal of Clinical Oncology, JCO. 23.02335, 2024 | 2 | 2024 |
| Learnings from implementing a surgical training program A Obermair, V Gebski, GB Hanna, MG Coleman, N Graves, A Tang, ... The University of Queensland, 2024 | | 2024 |
| Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer DS Zebic, A Tjokrowidjaja, KE Francis, M Friedlander, V Gebski, ... British Journal of Cancer 130 (3), 425-433, 2024 | 1 | 2024 |
| Feasibility and safety of a surgical training program in total laparoscopic hysterectomy: Results of a pilot trial A Obermair, GB Hanna, V Gebski, N Graves, MG Coleman, S Sanjida, ... Australian and New Zealand Journal of Obstetrics and Gynaecology 64 (1), 48-54, 2024 | 3 | 2024 |
| NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas (GI … LA Chantrill, D Ransom, D Chan, A Nagrial, N Pavlakis, B Markman, ... Journal of Clinical Oncology 42 (3_suppl), 589-589, 2024 | | 2024 |
| Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study GB Mann, AR Skandarajah, N Zdenkowski, J Hughes, A Park, D Petrie, ... The Lancet 403 (10423), 261-270, 2024 | 18 | 2024 |
| Proton versus photon therapy for esophageal cancer–A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton … HR Mortensen, P Populaire, L Hoffmann, DS Moeller, A Appelt, P Nafteux, ... Radiotherapy and Oncology 190, 2024 | 1 | 2024 |
| EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN ADVANCED SQUAMOUS CELL CARCINOMA OF THE LUNG. M Ameratunga, A Broad, N Pavlakis, V Gebski, M Khasraw Deakin University, 2023 | | 2023 |
| 586P Minimal residual disease (MRD) detection using a tumour naïve circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III … D Day, A Starus, V Gebski, J Simes, T Hayes, S Padinharakam, ... Annals of Oncology 34, S426-S427, 2023 | 2 | 2023 |
| ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An … J Lee, A Dean, T Price, K Sjoquist, V Gebski, J Mumford, F Day, S Yip, ... ESMO Gastrointestinal Oncology 1, 3-8, 2023 | 1 | 2023 |
| Individual participant data network meta-analysis of neoadjuvant chemotherapy or chemoradiotherapy in Esophageal or gastroesophageal junction carcinoma M Faron, M Cheugoua-Zanetsie, J Tierney, P Thirion, M Nankivell, ... Journal of Clinical Oncology 41 (28), 4535-4547, 2023 | 8 | 2023 |
| Neuropsychiatric correlates of olfactory identification and traumatic brain injury in a sample of impulsive violent offenders VM Challakere Ramaswamy, T Butler, B Ton, K Wilhelm, PB Mitchell, ... Frontiers in psychology 14, 1254574, 2023 | | 2023 |
| Australian radiation therapist's research capacity and culture: investigating the extent of assistance required to build research capacity R Beldham‐Collins, GKB Halkett, K Knight, V Gebski, C Wright Journal of Medical Radiation Sciences, 2023 | | 2023 |
| Self-reported traumatic brain injury in a sample of impulsive violent offenders: neuropsychiatric correlates and possible “dose effects” VM Challakere Ramaswamy, T Butler, B Ton, K Wilhelm, PB Mitchell, ... Frontiers in psychology 14, 1243655, 2023 | | 2023 |
| # 66 Survival of PARP inhibitor (PARPi) naïve ovarian cancer patients with a BRCA-mutation receiving maintenance olaparib after chemotherapy for first recurrence. An … JA Ledermann, I Ray-Coquard, R Penson, C Lee, A Oza, J Korach, ... International Journal of Gynecologic Cancer 33 (Suppl 3), 2023 | | 2023 |
| 10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection I Campbell, N Wetzig, O Ung, D Espinoza, G Farshid, J Collins, J Kollias, ... The Breast 70, 70-75, 2023 | 3 | 2023 |
| C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients VF Bonazzi, LG Aoude, S Brosda, JJ Bradford, JM Lonie, KA Loffler, ... Asia‐Pacific Journal of Clinical Oncology, 2023 | | 2023 |
